Experts Warned of Long-Term Corticosteroid Risks
New research highlights the health dangers of using topical steroids beyond their recommended two-to-three-week limit.
Updated on Sept. 28, 2026 in Asthma
Live Poll
Do you feel confident that your clinicians adequately monitor your long-term medication use?
Recent discussions at the National Corticosteroid Stewardship Summit emphasized that prolonged use of topical steroids can lead to serious adverse effects. This guidance aims to help patients and clinicians better monitor cumulative exposure to these medications.
Why it matters
Corticosteroid stewardship is increasingly vital for preventing systemic complications and skin damage from long-term use. Experts are now pushing for better tracking of cumulative exposure across different routes of administration to protect patient safety.
A 2026 prospective study of 688 patients with inflammatory diseases found that 17.4% were using active glucocorticoids. This follows a 2026 review linking high-dose or repeated systemic corticosteroids to significant adverse health outcomes.
The players
Adam Friedman
A medical expert who presented on the necessity of corticosteroid stewardship at a national summit.
The details
Topical corticosteroids are intended for short-term use, typically lasting two to three weeks, to manage inflammation without systemic absorption. When used improperly or for years, these treatments can cause skin thinning, fragility, bruising, and potential adrenal insufficiency. Clinicians are encouraged to perform regular medication reconciliation to identify patients at risk of unrecognized overexposure.
Timeline
A patient case report from 2025 documented adrenal insufficiency after 10 years of topical steroid use.
A 2026 review evaluated the cumulative health effects of various corticosteroid administration routes.
Adam Friedman presented his findings on September 22, 2026, in Washington, DC.
Health Landscape
The National Corticosteroid Stewardship Summit represents a significant step in formalizing clinical standards for medication management. This effort reflects a broader shift toward tracking cumulative drug exposure rather than viewing prescriptions as isolated, short-term events.
If you are using topical corticosteroids, confirm with your doctor how long you should continue the treatment and if you are approaching the recommended two-to-three-week limit. Be prepared to discuss your current medication list and any potential side effects like skin thinning during your next visit.
The takeaway
Chronic use of topical steroids carries real risks, including skin damage and hormonal issues like adrenal insufficiency. Always clarify the intended duration of your prescription with your physician to ensure you are not using these potent treatments longer than medically necessary.
Further reading
For more context on managing respiratory and inflammatory conditions, visit the Asthma section.
Live Poll
Do you feel confident that your clinicians adequately monitor your long-term medication use?
